Related Experiment Video
Updated: Feb 6, 2026

Studying Wnt Signaling During Patterning of Conducting Airways
Published on: October 16, 2016
An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
Amy Coopes1, Claire E Henry2, Estelle Llamosas3
1A Coopes, School of Women's and Children's Health, University of New South Wales Adult Cancer Program, Sydney, Australia.
Abstract:
Endometrial cancer is the most common gynaecological malignancy in developed nations, and its prevalence is rising as women defer or decide not to have children and as obesity rises, both key risk factors. Despite this, treatment options remain limited, particularly for advanced or refractory disease. New genomic analyses have revealed distinct mutational profiles with therapeutic and prognostic potential. Wnt signalling, which is pivotal in embryogenesis, healing and homeostasis, is of importance in the endometrium and has been linked to carcinogenesis. This review aims to update and discuss the current evidence for the role of β-catenin dependent and independent Wnt signalling, including the ROR receptors in the endometrium and its potential as a therapeutic target, in light of recent trials of Wnt-targeted therapy in multiple tumour types.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Synaptic Signaling
What is Cell Signaling?

